Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,261,353
+$1,948,034 QoQ
Shares Held
294,831
+86.3% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. IBRX ranks #137 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in IBRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,261,353 | 294,831 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $313,319 | 158,242 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $297,792 | 121,054 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $303,592 | 114,997 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $198,964 | 66,101 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $144,097 | 56,288 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $279,918 | 75,247 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $826,408 | 130,761 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $665,230 | 123,879 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $599,116 | 119,346 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $186,764 | 110,512 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $396,260 | 142,540 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $303,499 | 166,758 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $760,286 | 149,958 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $784,593 | 157,866 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $545,787 | 146,717 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $926,328 | 165,121 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,163,724 | 191,402 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,773,673 | 182,102 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,070,314 | 215,008 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,817,748 | 202,938 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||